Bio Usawa will be participating in the 6th Annual African Retina Society (ARS 2026) Conference, taking place on 12–13 June 2026 in Addis Ababa, Ethiopia. Our CEO and President, Dr. Menghis Bairu, and Director of Corporate Affairs, Richard Bishumba, will represent the company at this important gathering.

As retinal diseases continue to place a growing burden on patients and healthcare systems across Africa, expanding access to high-quality, affordable treatment options remains a critical priority.

Our engagements at the conference will explore how rigorous evaluation processes can strengthen confidence in anti-VEGF biosimilars, improve accessibility, and expand treatment opportunities for patients across the continent.

ARS 2026 provides a unique platform for clinicians, researchers, industry leaders, and policymakers to collaborate on practical solutions that advance retinal care in Africa.

We look forward to engaging with colleagues from across the region and contributing to the shared goal of improving patient outcomes through innovation, evidence, and equitable access.

If you'll be in Addis, you can book a meeting with our team via [email protected]